15^th World Congress on Endocrinology & Diabetes September 20-21, 2019 | Prague, Czech Republic

GERALD C. HSU has worked in various industries, including defense, nuclear power, computer-aided-design, computer hardware engineering, software development, semiconductor design, robotics, etc. He ventured in a very successful start-up and served as the Founder, Chairman, and CEO of a public traded company in Silicon Valley during 1994 to 2002, which specialized in artificial intelligence tools for semiconductor chip design. During the period of 1999 through 2002, he was also ranked as the highest paid CEO among 15,000 chief executives in Silicon Valley. GERALD C. HSU received an honorable PhD in mathematics and majored in engineering at MIT. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010 to 2013, then conducted his own diabetes research during 2014 to 2018. His approach is “quantitative medicine” based on mathematics, physics, optical and electronics physics, engineering modeling, signal processing, computer science, big data analytics, statistics, machine learning, and artificial intelligence. His main focus is on preventive medicine using prediction tools.

Endocrinology, Metabolism & metabolic disorders, Math-physical medicine (quantitative medicine) ,Chronic diseases (T2D)

Burd was the the Founder & CEO of DexCom, Inc., now the leader in continuous glucose monitoring. In 2017 he founded Lysulin, Inc, in order to launch a natural, scientifically proven nutraceutical product proven to improve the health of people with diabetes. The product, Lysulin was launched in January of 2018 and has been proven to work in double-blind placebo-controlled studies. He is also the founder and CEO of Wonder Spray, llc., a product to treat wound healing and other ailments. Dr Burd has authored over 40 publications and hold 35 issued patents. In 2010 he was inducted into the American Association of Clinical Chemistry Hall of Fame and received the Ullman Prize for innovation in clinical chemistry.

Diabetes, Endocrinology

Francesco Lippi is Graduated in Medicine and Surgery at the University of Pisa, Albo Pisa 1879/79. Specialization in Endocrinology at the University of Pisa July 1982. Specialization in Nuclear Medicine at the University of Florence July 1987. He has taught at the Institute of Clinical Methodology and the Institute of Endocrinology of the University of Pisa. From 1990 as a Professor of Endocrinology at the University Hospital of Pisa. He conducted the study (pahe se III) on effects of recombinant human TSH (rhTSH) adjuvant therapy in compassionate use program for patients with differentiated thyroid carcinoma. Then used a low activiy of radiodine therapy for treatment of thyroid remnants after surgery using rhTSH therapy without widrawall l-tiroxine. After Chernobyl accident partecipate to European Commision Study for diagnosis and tratment of children exposed to the radiations or radioactive follow-out (1990-1995). He held master's and refresher courses in Endocrinology and Nuclear Medicine at Stanford University (USA) for the treatment of thyroid carcinoma with rhTSH. He held an update master's degree at the Mayo Clinic in Rochester (USA). Associate of scientific associations in the field of Endocrinology as Endocrine Society, American Thyroid Association, European Thyroid Association and Medical Endocrinolist Association (AME).

Endocrinology, Nuclear Medicine, thyroid carcinoma

Gundu H. R. Rao obtained his B.Sc degree from the University of Mysore and B.Sc (Hons) and M.Sc., degrees from the Poona University. He worked for an year with the Commonwealth Institute of Biological Control, Bangalore and five years at the Central Food Technological Research Institute, Mysore. He immigrated to the USA in 1965 and specialized in grain storage technology and obtained his Ph.D degree from the Kansas State University, Manhattan, Kansas. After working as a post-doctoral fellow at the Texas A& M University and University of Minnesota, he joined department of Pharmacology as an NIH fellow to get training in toxicology. He has been with the University of Minnesota Medical School for over 40 years. He is a naturalized US citizen and a tenured professor in the department of Laboratory Medicine & Pathology. He also has faculty appointments in Anesthesiology, Lillehei Heart Institute, and Biomedical Engineering Institute. He is an author or co-author of over 300 publications in the field of interest (thrombosis and stroke). In the past, he has consulted various medical device development companies in the Twin Cities including 3M, Medtronic Inc, St Jude Medical, Medical CV Inc, Vascular Solutions, APP Tech, Endocardial Solutions, PlaCor Inc., Medical Innovations Inc, Hypertension Diagnostics Inc. and Boston Scientific on problems related to biocompatibility, thrombosis and stroke.

Pharmacology, Laboratory Medicine & Pathology, Anesthesiology, thrombosis and stroke

Joseph Fomusi Ndisang is an Associate Professor in the University of Saskatchewan College of Medicine, Department of Physiology. He received postdoctoral training in Physiology at the University of Saskatchewan College of Medicine from 200-2005. He received a PhD in Pharmacology & Toxicology from the University of Florence, Italy, 2000. He received a Doctor of Pharmacy degree from University of Florence, Italy in 1995. He has received several distinguished awards and distinctions including: Fellow of the American Heart Association (FAHA) in 2011; Fellow of the International College of Angiology (FICA) in 2007; Young Investigator Award by International College of Angiology (2007); Young Investigator Award by the American Society of Pharmacology & Experimental Therapeutics- Division for Drug Discovery, Development & Regulatory Affairs (2005); Young Investigator Award by the Society of Experimental Biology and Medicine (2005); Recognition Award for Meritorious Research by a Young Investigator by the American Physiological Society (2004). He has published 36 manuscripts, 57 abstracts, 2 book chapters, 1 book and has served peer-reviewer for may highly reputed journals and funding agencies in United States, United kingdom and Canada and has also served as external PhD examiner in Canada and internationally.Currently, Dr. Ndisang is an Editor for Frontiers in Bioscience (impact factor 3.8) and Executive Guest Editor for Current Medicinal Chemistry (impact factor 3.7) He has published more than 64-full length manuscripts in peer-reviewed journals and more than 80 abstracts. Dr. Ndisang has served as external PhD examiner for several universities in Canada, has given more than 30-invited talks, and has also served as peer-reviewer for several reputed journals and granting agencies in United States, United Kingdom, Canada, New Zealand and Poland.

Heme oxygenase system in hypertension, diabetes (types-1 and -2), and obesity

Dr Ellahham is currently Cleveland Clinic Caregiver, Cleveland, US seconded as Senior Cardiovascular Consultant and Quality Advisor in Cleveland Clinic Abu Dhabi. Dr. Ellahham received his undergraduate degree in biology and his M.D. from the American University of Beirut, Beirut, Lebanon. Dr Ellahham finished his internal medicine residency in Georgetown University Hospital - Washington Hospital Center and his fellowship in Cardiology at the Virginia Commonwealth University Health System in USA.Dr. Ellahham worked in Washington DC in Georgetown University Hospital - Washington Hospital Center and in several clinical and leadership positions before moving to UAE in 2008. Dr. Ellahham continues to be an active clinician. He demonstrates great skill and experience in the management of patients with heart failure, ischemic heart disease, and valvular heart disease and led a multi-disciplinary team in the care and delivery of advanced therapies to these patients. He has unique abilities to partner and engage local and regional referring providers. He can work in a highly matrixed environment, possess strong leadership and organizational skills and have experience to working effectively in a large health system. He led the First AHA GWTG Heart Failure Initiative outside US and was the recipient of the AHA GWTG Award in Wash. DC. He is the champion of the AHA GWTG in the region.

Heart and Diabetes, Six Sigma, change management, innovation, safety, outcomes research, risk management, safe surgery, genetics, cardiac imaging, sports and nutrition

Vladimír Štrbák has worked at Institute of Experimental Endocrinology, Slovak Academy of Sciences. He was Organizer and chairman of the five International symposia on Hormones in Milk, resident of the International Symposium on Cell volume and function 1997. He was Organizer and chairman Symposium Cell Volume, physiological and pathophysiological aspects, 5th International Congress of Pathophysiology, June 28-July 1, 2006,Beijing, China, published in Chinese Journal of Pathophysiology, June 2006, Volume 22, No 13, Supplement p. 167. Organizer and chairman of the session Cell Volume Regulation and Cell Functions The Physiology of Anion Transport and Cell Volume Regulation (August 3-6, 2009, Okazaki, Japan) Symposium following the IUPS Congres (Kyoto). Most important activities in last three years: 6th Global Diabetes Summit and Medicare Expo, November 02-04, 2015, Dubai, UAE, Organizing Committe Member, Keynote speaker. 13th Global Diabetes Conference and Medicare Expo, August 8-10, 2016, Birmingham, UK:Organizing Committe Member Keynote speaker. 16th Global Diabetes Conference and Medicare Expo, March 22-23, 2017 Rome, Italy Organizing Committe Member, Keynote speaker, Chair of the Session.

Endocrinology, Diabetes and Pathophysiology

Eduardo J. Simoes MD, MSc, MPH completed his medical degree from Faculdade de Medicina, Universidade de Pernambuco (Brazil) in 1981, Master of Science in Community Health and Diploma of Hygiene and Tropical Medicine from the London School of Hygiene and Tropical Medicine, University of London (England) in 1987, and Master of Public Health from Emory School of Public Health, Emory University (United States) in 1991. He is the chair, Dr. Stuart Wesbury distinguished professor and HMI Alumni distinguished professor of the Department of Health Management and Informatics of the University Of Missouri School Of Medicine (since September 27, 2011). He served as primarycare physician, health district planner, and director of three Primary Healthcare Clinics in the City of Recife Secretariat of Health (1980-1989). He was a visiting associate with the Centers for Diseases Control and Prevention (1991-1993), associate researcher of Emory University School of Medicine (1994), medical and state epidemiologist with the Missouri Department of Health (1995-2003). He was director of the Prevention Research Centers Program Office of the Centers for Disease Control and Prevention (February 2003- September 2011), assistant and adjunct professor of Saint Louis University School of Public Health (1995-2011). His research work includes etiological studies, public health practice research, and evaluation of population-based interventions. His public health work includes development of disease prevention and health promotion programs, surveillance systems and evaluation of public health interventions. Dr. Simoes has 136 publications in peer-reviewed journals, 13 book chapters and over 150 presentations in national and international conferences. He is a fellow of the American College of Epidemiology, member of the Society for Epidemiological Research and American College of Healthcare Executives. He serves as an editorial board member of scientific journals of repute and consultant of many international and national health organizations.

Health Management and Informatics, Epidemiology, Disease Control and Prevention, public health practice research, etiological studies and evaluation of population-based interventions

Wei-Chiang Shen is a Professor in Pharmaceutical Sciences at the University Of Southern California School Of Pharmacy. His research interests focus on the development of novel systems for improving peptide and protein drug delivery. He has published more than 150 papers in different areas of biomedical sciences. He is a Co-Author of the textbook “Immunology” for Pharmacy Students and a Co-editor of the book “Antibody-Drug Conjugates – the 21st Century Magic Bullets for Cancer”. He was elected to Fellow of the American Association of Pharmaceutical Scientists in 1992 and Fellow of the American Association for the Advancement of Sciences in 2000

Cancer Treatment, Membranes & Transport, Protein Chemistry/Enzymology, Drug Design, Delivery